Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Futreal

Showing results (41-50 of 389) with videos related to

Pageof 39
Sort By:
Nature Genetics|February 7, 2020
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancerKadir C Akdemir, Victoria T Le, Sahaana Chandran, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2016
Antitumor Response of VEGFR2- and VEGFR3-Amplified Angiosarcoma to PazopanibVinod Ravi, Eric M Sanford, Wei-Lien Wang, et al.
Nature Genetics|March 22, 2023
Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancerKadir C Akdemir, Victoria T Le, Sahaana Chandran, et al.
Genes, Chromosomes & Cancer|April 17, 2012
Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinomaMarta Persson, Ywonne Andrén, Christopher A Moskaluk, et al.
Psychoneuroendocrinology|February 8, 2018
Associations of inflammation with symptom burden in patients with acute myeloid leukemiaTamara E Lacourt, Annemieke Kavelaars, Jessica R Galloway-Peña, et al.
Genetic Testing|September 7, 2002
Pre-counseling education materials for BRCA testing: does tailoring make a difference?Celette Sugg Skinner, Joellen M Schildkraut, Donald Berry, et al.
Frontiers in Immunology|April 29, 2021
Response to Hypomethylating Agents in Myelodysplastic Syndrome Is Associated With Emergence of Novel TCR ClonotypesHussein A Abbas, Patrick K Reville, Xianli Jiang, et al.
Cancer Immunology, Immunotherapy : CII|January 7, 2021
Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitorsNoha Abdel-Wahab, Adi Diab, Robert K Yu, et al.
Journal of Translational Medicine|April 22, 2022
The "Great Debate" at Immunotherapy Bridge 2021, December 1st-2nd, 2021Paolo A Ascierto, Lisa H Butterfield, Olivera J Finn, et al.
Ejhaem|July 18, 2022
Fidelity of peripheral blood for monitoring genomics and tumor immune-microenvironment in myelodysplastic syndromesSung-Eun Lee, Feng Wang, Abel Trujillo-Ocampo, et al.
Pageof 39

Showing results (41-50 of 389) with videos related to

Sort By:
Pageof 39
Nature Genetics|February 7, 2020
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancerKadir C Akdemir, Victoria T Le, Sahaana Chandran, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2016
Antitumor Response of VEGFR2- and VEGFR3-Amplified Angiosarcoma to PazopanibVinod Ravi, Eric M Sanford, Wei-Lien Wang, et al.
Nature Genetics|March 22, 2023
Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancerKadir C Akdemir, Victoria T Le, Sahaana Chandran, et al.
Genes, Chromosomes & Cancer|April 17, 2012
Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinomaMarta Persson, Ywonne Andrén, Christopher A Moskaluk, et al.
Psychoneuroendocrinology|February 8, 2018
Associations of inflammation with symptom burden in patients with acute myeloid leukemiaTamara E Lacourt, Annemieke Kavelaars, Jessica R Galloway-Peña, et al.
Genetic Testing|September 7, 2002
Pre-counseling education materials for BRCA testing: does tailoring make a difference?Celette Sugg Skinner, Joellen M Schildkraut, Donald Berry, et al.
Frontiers in Immunology|April 29, 2021
Response to Hypomethylating Agents in Myelodysplastic Syndrome Is Associated With Emergence of Novel TCR ClonotypesHussein A Abbas, Patrick K Reville, Xianli Jiang, et al.
Cancer Immunology, Immunotherapy : CII|January 7, 2021
Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitorsNoha Abdel-Wahab, Adi Diab, Robert K Yu, et al.
Journal of Translational Medicine|April 22, 2022
The "Great Debate" at Immunotherapy Bridge 2021, December 1st-2nd, 2021Paolo A Ascierto, Lisa H Butterfield, Olivera J Finn, et al.
Ejhaem|July 18, 2022
Fidelity of peripheral blood for monitoring genomics and tumor immune-microenvironment in myelodysplastic syndromesSung-Eun Lee, Feng Wang, Abel Trujillo-Ocampo, et al.
Pageof 39